
Sign up to save your podcasts
Or


Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.

91,297 Listeners

38,950 Listeners

113,121 Listeners

8,876 Listeners

99,698 Listeners

9,194 Listeners

41 Listeners

189 Listeners

68 Listeners

31 Listeners

2 Listeners

154 Listeners

1,246 Listeners

3,697 Listeners